Rare Seizure Disorder First Drug Approval

“There has been a great unmet medical need for treatments that
address seizures associated with CDKL5 deficiency disorder given
their prominent role and profound impact on patients,” said Scott
Demarest,of Children’s Hospital Colorado [and CU School of
Medicine], principal investigator for the Marigold trial, in a statement.